Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

OphthalmicPress Release
China’s Crackdown on Health Agencies Opens Door for Global Ophthalmic Firms

China's massive overhaul of its health agencies is continuing the Communist Party's push to open the country to more health care therapies and technologies. The move is creating new opportu...

FDA Publishes Throckmorton’s Statement on Opioid Tapering

Douglas Throckmorton, MD, from the FDA Center for Drug Evaluation issued a statement on opioid analgesic label changes. The FDA published the statement on April 9 to give physicians guidelines for ...

FDA Announces Final Classification of Posterior Cervical Screws

The US FDA announced April 1 that it has classified posterior cervical screw systems as Class II, devices with special controls. This classification will come into full effect May 1, 2019. After th...

Scilex, Semnur Merge to Form Non-Opioid Pain Management Company

Sorrento Therapeutics announced March 22 that its subsidiary Scilex Pharmaceuticals is merging with privately owned Semnur Pharmaceuticals to form Scilex Holding Company. Scilex’ lead product is ZT...

Ocugen, Histogenics Agree to Reverse Merger

Privately held Ocugen will become a public company in a reverse merger with orthopedics company Histogenics, the two announced April 8. The transaction is expected to close late in Q2-2019 or in Q3...

Supreme Court Refuses to Hear Allergan’s Appeal over Restasis Patents

The US Supreme Court has rejected Allergan’s bid to use tribal sovereign immunity to protect Restasis’ patents from inter partes review proceedings. The court refused April 12 to hear Allergan’s ap...

Ophthotech Rebrands as Iveric after Licensing Gene Therapy Program

Ophthotech has changed its name to Iveric bio and updated its ticker symbol on the Nasdaq Global Select Market to “ISEE.” The New York company said April 16 that the move reflects its new focus on ...

US FDA Accepts Novartis’ BLA for Brolucizumab in Wet AMD

Novartis announced April 15 that the US FDA has accepted its biologics license application for brolucizumab (RTH258) for wet age-related macular degeneration. The Swiss company said it used a prior...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

US Surveys
May select more than one
Outside of US Surveys

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2019 Market Scope, LLC. All Rights reserved.